HealthLynked Corp.
HLYK · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.08 | 0.06 | 0.12 | 0.03 |
| FCF Yield | 0.00% | -7.40% | -5.27% | -12.34% |
| EV / EBITDA | -22.76 | -29.15 | -15.77 | -11.25 |
| Quality | ||||
| ROIC | -81.85% | -59.91% | 20.40% | 35.13% |
| Gross Margin | 97.58% | 97.30% | 97.70% | 98.50% |
| Cash Conversion Ratio | – | 0.60 | 0.41 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.37% | -24.82% | -22.66% | -19.92% |
| Free Cash Flow Growth | 100.00% | 3.47% | 41.83% | 28.11% |
| Safety | ||||
| Net Debt / EBITDA | -11.91 | -14.34 | -1.85 | -1.49 |
| Interest Coverage | 10.29 | -1.49 | -9.21 | -1.28 |
| Efficiency | ||||
| Inventory Turnover | 0.29 | 0.58 | 0.55 | 0.21 |
| Cash Conversion Cycle | 644.58 | -2,861.42 | -2,413.82 | -3,908.83 |